WITHDRAWAL OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO ATTAINED STABLE LOW DISEASE ACTIVITY WITH ADALIMUMAB PLUS METHOTREXATE: RESULTS OF A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

Emery, Paul ^{[2
]}

Fleischmann, Roy ^{[3
]}

van Vollenhoven, Ronald ^{[4
]}

Pavelka, Karel ^{[5
]}

Durez, Patrick ^{[6
]}

Guerette, Benoit ^{[7
]}

Santra, Sourav ^{[8
]}

Redden, Laura ^{[8
]}

Kupper, Hartmut ^{[9
]}

Smolen, Josef S. ^{[10
,11
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA

[2] Leeds Teaching Hosp, Dept Rheumatol, Leeds, W Yorkshire, England

[3] Univ Texas SW Med Ctr Dallas, Dept Rheumatol, Dallas, TX 75390 USA

[4] Karolinska Inst, Dept Rheumatol, Stockholm, Sweden

[5] Charles Univ Prague, Dept Rheumatol, Prague, Czech Republic

[6] Catholic Univ Louvain, Dept Rheumatol, B-1348 Louvain, Belgium

[7] Abbott, GPRD, Rungis, France

[8] Abbott, GPRD, Abbott Pk, IL USA

[9] Abbott, GPRD, Ludwigshafen, Germany

[10] Med Univ Vienna, Dept Rheumatol, Vienna, Austria

[11] Hietzing Hosp, Vienna, Austria

来源：

RHEUMATOLOGY | 2012年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：29 / 30

页数：2

共 50 条

[1] Withdrawal of Adalimumab in Early Rheumatoid Arthritis Patients Who Attained Stable Low Disease Activity with Adalimumab Plus Methotrexate: Results of a Phase 4, Double-Blind, Placebo-Controlled Trial
Kavanaugh, Arthur
Emery, P.
Fleischmann, Roy
van Vollenhoven, Ronald F.
Pavelka, Karel
Durez, Patrick
Guerette, Benoit
Santra, Sourav
Redden, Laura
Kupper, Hartmut
Peterson, Theresa
Smolen, Josef
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S666
[2] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial
Fleischmann, Roy
Pangan, Aileen L.
Song, In-Ho
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, AndrewJ
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1788 - 1800
[3] Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis
S B Krintel
C Dehlendorff
M L Hetland
K Hørslev-Petersen
K K Andersen
P Junker
J Pødenphant
T Ellingsen
P Ahlquist
H M Lindegaard
A Linauskas
A Schlemmer
M Y Dam
I Hansen
H C Horn
A Jørgensen
J Raun
C G Ammitzbøll
M Østergaard
K Stengaard-Pedersen
J S Johansen
The Pharmacogenomics Journal, 2016, 16 : 141 - 146
[4] Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis
Krintel, S. B.
Dehlendorff, C.
Hetland, M. L.
Horslev-Petersen, K.
Andersen, K. K.
Junker, P.
Podenphant, J.
Ellingsen, T.
Ahlquist, P.
Lindegaard, H. M.
Linauskas, A.
Schlemmer, A.
Dam, M. Y.
Hansen, I.
Horn, H. C.
Jorgensen, A.
Raun, J.
Ammitzboll, C. G.
Ostergaard, M.
Stengaard-Pedersen, K.
Johansen, J. S.
PHARMACOGENOMICS JOURNAL, 2016, 16 (02): : 141 - 146
[5] Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial
Sode, Jacob
Krintel, Sophine B.
Carlsen, Anting Liu
Hetland, Merete L.
Johansen, Julia S.
Horsley-Petersen, Kim
Stengaard-Pedersen, Kristian
Ellingsen, Torkell
Burton, Mark
Junker, Peter
Ostergaard, Mikkel
Heegaard, Niels H. H.
JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 53 - 61
[6] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
Mease, PJ
Gladman, DD
Ritchlin, CT
Ruderman, EM
Steinfeld, SD
Choy, EHS
Sharp, JT
Ory, PA
Perdok, RJ
Weinberg, MA
ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
[7] Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial
Ruyssen-Witrand, Adeline
Brusq, Clara
Masson, Maeva
Bongard, Vanina
Salliot, Carine
Poiroux, Lucile
Nguyen, Minh
Roux, Christian Hubert
Richez, Christophe
Saraux, Alain
Vergne-Salle, Pascale
Morel, Jacques
Flipo, Rene-Marc
Piperno, Muriel
Gottenberg, Jacques-Eric
Marotte, Hubert
Soubrier, Martin
Gossec, Laure
Dieude, Philippe
Lassoued, Slim
Zabraniecki, Laurent
Couture, Guillaume
Boyer, Jean Frederic
Jamard, Benedicte
Degboe, Yannick
Constantin, Arnaud
ANNALS OF THE RHEUMATIC DISEASES, 2024,
[8] Treatment of early rheumatoid arthritis with minocycline or placebo - Results of a randomized, double-blind, placebo-controlled trial
ODell, JR
Haire, CE
Palmer, W
Drymalski, W
Wees, S
Blakely, K
Churchill, M
Eckhoff, PJ
Weaver, A
Doud, D
Erikson, N
Dietz, F
Olson, R
Maloley, P
Klassen, LW
Moore, GF
ARTHRITIS AND RHEUMATISM, 1997, 40 (05): : 842 - 848
[9] Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
Smolen, Josef S.
Emery, Paul
Fleischmann, Roy
van Vollenhoven, Ronald F.
Pavelka, Karel
Durez, Patrick
Guerette, Benoit
Kupper, Hartmut
Redden, Laura
Arora, Vipin
Kavanaugh, Arthur
LANCET, 2014, 383 (9914): : 321 - 332
[10] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
van der Heijde, Desiree
Kivitz, Alan
Schiff, Michael H.
Sieper, Joachim
Dijkmans, Ben A. C.
Braun, Juergen
Dougados, Maxime
Reveille, John D.
Wong, Robert L.
Kupper, Hartmut
Davis, John C., Jr.
ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146

← 1 2 3 4 5 →